These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11223270)

  • 41. Animal-derived surfactant treatment of respiratory distress syndrome in premature neonates: a review.
    Fujii AM; Carillo M
    Drugs Today (Barc); 2009 Sep; 45(9):697-709. PubMed ID: 19956811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage.
    Pandit PB; Dunn MS; Colucci EA
    Pediatrics; 1995 Jan; 95(1):32-6. PubMed ID: 7770305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future.
    Sardesai S; Biniwale M; Wertheimer F; Garingo A; Ramanathan R
    Pediatr Res; 2017 Jan; 81(1-2):240-248. PubMed ID: 27706130
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proceedings of the 24th International Workshop on Surfactant Replacement. Workshop dedicated in memory of Bengt Robertson. Ljubljana, Slovenia June 4-6, 2009.
    Neonatology; 2009; 95(4):340-80. PubMed ID: 19757515
    [No Abstract]   [Full Text] [Related]  

  • 45. Different effects of surfactant proteins B and C - implications for development of synthetic surfactants.
    Curstedt T; Johansson J
    Neonatology; 2010 Jun; 97(4):367-72. PubMed ID: 20551705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The exogenous surfactant and its effect on the respiratory distress syndrome (RDS)].
    Brabec R; Zoban P; Tomásová H
    Cesk Fysiol; 1996 Sep; 45(3):139-45. PubMed ID: 8974827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The future of surfactant therapy for patients with acute lung injury - new requirements and new surfactants.
    Spragg RG
    Biol Neonate; 2002; 81 Suppl 1():20-4. PubMed ID: 12011562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
    Soll RF; Blanco F
    Cochrane Database Syst Rev; 2001; (2):CD000144. PubMed ID: 11405951
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exogenous surfactant administration during the transport of premature infants.
    Riek KM
    Air Med J; 2004; 23(5):8-9. PubMed ID: 15337930
    [No Abstract]   [Full Text] [Related]  

  • 50. [Surfactant replacement therapy in neonatal respiratory distress syndrome: prophylactic therapy versus treating of established disease].
    Lubetzky R; Dolberg S
    Harefuah; 1999 Nov; 137(10):464-7. PubMed ID: 10959346
    [No Abstract]   [Full Text] [Related]  

  • 51. Surfactant replacement therapy in neonatal respiratory distress syndrome.
    Hellmann J
    Paediatr Anaesth; 1995; 5(2):81-8. PubMed ID: 7489429
    [No Abstract]   [Full Text] [Related]  

  • 52. [Substitutive therapy with surfactants in premature infants with respiratory distress syndrome].
    Liberatore A; Carrera G; Calciolari G; Coccia C; Coppalini B; Fulconis F; Moro G; Scimone F; Villa G; Minoli I
    Ann Osp Maria Vittoria Torino; 1987-1988; 30():28-35. PubMed ID: 3334194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic disorders of neonatal respiratory function.
    Cole FS; Hamvas A; Nogee LM
    Pediatr Res; 2001 Aug; 50(2):157-62. PubMed ID: 11477198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surfactant protein A and surfactant protein D in health and disease.
    Mason RJ; Greene K; Voelker DR
    Am J Physiol; 1998 Jul; 275(1):L1-13. PubMed ID: 9688929
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of exogenous surfactant on total respiratory system compliance.
    Milner AD; Vyas H; Hopkin IE
    Arch Dis Child; 1984 Apr; 59(4):369-71. PubMed ID: 6372707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surfactant for the treatment of respiratory distress syndrome.
    Jobe A; Ikegami M
    Am Rev Respir Dis; 1987 Nov; 136(5):1256-75. PubMed ID: 3314618
    [No Abstract]   [Full Text] [Related]  

  • 57. Surfactant. Evolving issues.
    Kattwinkel J
    Clin Perinatol; 1998 Mar; 25(1):17-32. PubMed ID: 9523072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surfactant-associated proteins in tracheal aspirates of infants with respiratory distress syndrome after surfactant therapy.
    Chida S; Phelps DS; Cordle C; Soll R; Floros J; Taeusch HW
    Am Rev Respir Dis; 1988 Apr; 137(4):943-7. PubMed ID: 3355003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advances with surfactant.
    Turell DC
    Emerg Med Clin North Am; 2008 Nov; 26(4):921-8, viii. PubMed ID: 19059091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surfactant proteins and anti-surfactant antibodies in sera from infants with respiratory distress syndrome with and without surfactant treatment.
    Chida S; Phelps DS; Soll RF; Taeusch HW
    Pediatrics; 1991 Jul; 88(1):84-9. PubMed ID: 2057277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.